Reuters Photojournalism
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography. See more | Photo caption
The SpaceX mission
A privately owned unmanned rocket blasts off on a mission to be the first commercial flight to the International Space Station. Slideshow
U.S. to aggressively pursue drug misbranding cases
WASHINGTON |
WASHINGTON (Reuters) - The U.S. Department of Justice will continue to "aggressively pursue" pharmaceutical companies that illegally market drugs for uses that have not been approved by health regulators, a top agency official said on Wednesday.
"These cases are cases that we will continue to aggressively pursue," Tony West, assistant attorney general for the Justice Department's civil division, told reporters after announcing a plea deal with Allergan Inc.
He said the Allergan case, in which the company will pay $600 million in penalties and plead guilty to a misdemeanor charge, creates a deterrent in the industry.
(Reporting by Jeremy Pelofsky, editing by Maureen Bavdek)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters